Founding Date | Founding Date 2016 | Founding Date 1997 | Founding Date 2003 | Founding Date 2015 | Founding Date 2009 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations TW HQ San Mateo, US | Locations Planegg, DE HQ | Locations Modi'in-Maccabim-Re'ut, IL HQ | Locations Hemel Hempstead, GB HQ | Locations Suzhou Shi, CN HQ |
Employees | Employees 514% increase | Employees 13 | Employees 2414% decrease | Employees 965% decrease | Employees 42 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 74 m | Valuation ($) 38.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €336k (FY, 2024) | Revenue (est.) $1.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €84k (FY, 2024) | Cost of goods $230k (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €261k (FY, 2024) | Gross profit $950k (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income (€8.3m) (FY, 2024) | Net income ($2m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 9.1m (almost 19 years ago) | Latest funding round $ 60m (about 7 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 100.9m | Total funding raised $ 54.2m | Total funding raised $ 160m |

4SC is a biopharmaceutical company developing small-molecule drugs for the treatment of cancer.
View company
BioLineRx is a biopharmaceutical company focused on oncology.
View company
EUSA Pharma is a biopharmaceutical company focused on oncology and rare diseases.
View company
Alphamab Oncology is a clinical-stage biopharmaceutical company.
View company